Leuprorelin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
| (1 revisi perantara oleh pengguna yang sama tidak ditampilkan) | |||
Baris 20:
| pregnancy_AU_comment =
| pregnancy_category=
| routes_of_administration = [[
| class = [[GnRH analogue]]; [[GnRH agonist]]; [[Antigonadotropin]]
| ATC_prefix = L02
Baris 60:
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 53714-56-0
| CAS_supplemental = <br />{{CAS|74381-53-6}} ([[
| PubChem = 657181
| IUPHAR_ligand = 1175
Baris 77:
| NIAID_ChemDB =
| PDB_ligand =
| synonyms =
<!-- Chemical and physical data -->
Baris 107:
* [https://web.archive.org/web/20070928130833/http://pitap.abbott.com/showpi.asp?PI=luproninjection Lupron Injection] (package insert from abbott)
* [https://web.archive.org/web/20070228153619/http://www.freewebs.com/adamshajnfeld/article.htm Reforming (purportedly) Non-Punitive Responses to Sexual Offending] (journal article discussing use of Lupron as a form of reforming sex offender law)
==Bacaan lebih lanjut==
{{refbegin}}
[[Kategori:RTT]]▼
* {{cite journal | vauthors = Shajnfeld A, Krueger RB | title=Reforming (Purportedly) Non-Punitive Responses to Sexual Offending | website=Developments in Mental Health Law | date=July 2006 | volume=25 | page=81 | ssrn=1077282}}
{{refend}}
[[Kategori:Obat yang dikembangkan oleh AbbVie]]
[[Kategori:Obat antineoplastik hormonal]]
[[Kategori:Terapi peptida]]
[[Kategori:Obat yang dikembangkan oleh Takeda Pharmaceutical Company]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
{{Farmasi-stub}}
| |||